Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Paul Arnold"


7 mentions found


UBS to expand presence in U.S. market - Swiss paper
  + stars: | 2023-12-03 | by ( ) www.reuters.com   time to read: 1 min
A UBS logo is seen next to Credit Suisse at the Bahnhofstrasse before a news conference of Swiss bank UBS in Zurich Switzerland, August 30, 2023. REUTERS/Denis Balibouse/File Photo Acquire Licensing RightsDec 3 (Reuters) - Swiss bank UBS (UBSG.S) plans to expand its presence in the U.S. market as part of its strategy to hit $150 billion in net new money, or inflow of new funds, per year, an executive told Swiss newspaper NZZ Am Sonntag in an interview published on Sunday. The fourth-largest asset manager in the United States plans to invest heavily over the next three years, Iqbal Kahn, head of its asset management division, told the paper. Reporting by Victoria Waldersee, Paul Arnold Editing by Bernadette BaumOur Standards: The Thomson Reuters Trust Principles.
Persons: Denis Balibouse, NZZ, Iqbal Kahn, Victoria Waldersee, Paul Arnold, Bernadette Baum Organizations: UBS, Credit Suisse, Swiss, REUTERS, Thomson Locations: Zurich Switzerland, Swiss, U.S, United States
LONDON, Nov 29 (Reuters) - Swiss insurer Baloise (BALN.S) is in talks to sell around 1 billion euros ($1.1 billion) of life insurance policies in Belgium, two people familiar with the matter told Reuters. The efforts come as other traditional insurers sell non-core portfolios with a view to freeing up capital held against those liabilities. In 2020, the Swiss group purchased the non-life insurance operations of Apollo-backed Athora. Baloise saw premiums in its non-life insurance business grow by close to 6% in the first nine months of the year to 3.4 billion Swiss francs ($3.9 billion) globally. However, life insurance premiums dropped more than 4% to 2.9 billion francs during the same period, according to its latest earnings release.
Persons: Baloise, Pablo Mayo, Paul Arnold, Anousha Sakoui, Mark Potter Organizations: Baloise, Reuters, The, ING Groep, ING, Aegon, Royal London, Swiss, Apollo, Fidea, Pablo Mayo Cerqueiro, Thomson Locations: Belgium, The Basel, London, Zurich
BERLIN, Aug 23 (Reuters) - Roche (ROG.S) inadvertently published positive lung cancer drug trial data from an interim analysis, boosting the Swiss drug maker's shares even though more data will be needed to confirm the treatment's efficacy. Roche said on Wednesday that market participants had made it aware of the inadvertent disclosure of an interim data analysis on new immunotherapy tiragolumab, part of an experimental class of drugs known as anti-TIGIT. The data lifted Roche shares by 5% and sent shares of other companies testing anti-TIGIT drugs higher. J.P. Morgan analysts said the interim data suggested a survival benefit was within reach in the final analysis, but the clinical relevance remained uncertain. The unintended disclosure regards the second interim analysis of a Phase III trial known as Skyscraper 1.
Persons: Roche, tiragolumab, Morgan, Roche's, TIGIT, Paul Arnold, Christy Santhosh, Jason Neely, Friederike Heine, Mark Potter Organizations: Merck & Co, Gilead Sciences, iTeos Therapeutics, Arcus Biosciences, Thomson Locations: U.S, Zurich, Bengaluru
July 20 (Reuters) - Bain Capital has increased its offer for SoftwareOne Holding AG to about 3.2 billion Swiss francs ($3.72 billion), Bloomberg News reported on Thursday, citing people with knowledge of the matter. The private equity firm has tabled a new proposal of around 20 francs per share for the Swiss software management company, the report said. SoftwareOne and Bain Capital declined to comment on the report. The reported new offer is at a premium of 43.6% from SoftwareOne's last close on May 31, when Bain first presented an offer to the Swiss firm valuing it at $3.2 billion. SoftwareOne helps companies manage software purchases from vendors such as Microsoft, Adobe and IBM.
Persons: SoftwareOne, Bain, Daniel von Stockar, Rene Gilli, Kanjyik Ghosh, Paul Arnold, David Evans, Jan Harvey, Frances Kerry Organizations: Bain Capital, SoftwareOne, Bloomberg, Microsoft, Adobe, IBM, Thomson Locations: Swiss, SoftwareOne's, Bengaluru, Zurich
[1/3] Logos of Swiss banks UBS and Credit Suisse are seen in Zurich, Switzerland March 20, 2023. Switzerland's credibility as a stable, predictable country had been upended by moves like the decision to wipe out the holdings of Credit Suisse bondholders, he said. Under the takeover deal, holders of Credit Suisse AT1 bonds will get nothing, while shareholders, who usually rank below bondholders in compensation terms, will receive $3.23 billion. "In that sense I also see a prosperous future for the financial centre because we have hundreds of very well capitalised banks and very successful wealth management and asset management banks." Reuters Graphics Reuters GraphicsReuters GraphicsOthers were more skeptical about the future, highlighting a reluctance to confront mistakes at Credit Suisse or take responsibility for the aftermath.
ZURICH, March 13 (Reuters) - Swiss financial regulator FINMA on Monday said it was closely monitoring the banks and insurers it oversees after the U.S. moved to guarantee the deposits of two failing lenders in an effort to stem contagion. "FINMA takes note of the media reports on Silicon Valley Bank and Signature Bank in the USA and is closely monitoring the situation," FINMA said in a statement. "FINMA is evaluating the direct and indirect exposure of the banks and insurance companies it supervises to the institutions concerned," it said. FINMA said it was in contact with various institutions which could be affected, but declined name them or the measures it might take. The Swiss National Bank declined to comment on the effect of the Silicon Valley Bank's collapse could have on Switzerland's financial sector.
ZURICH, Feb 20 (Reuters) - Swiss financial regulator Finma is reviewing remarks made by Credit Suisse Group (CSGN.S) Chairman Axel Lehmann about outflows from the lender having stabilized in early December, two people with knowledge of the matter told Reuters. Lehmann told the Financial Times in an interview streamed online on Dec. 1 that after strong outflows in October, they had "completely flattened out" and "partially reversed". Credit Suisse shares rose 9.3% on Dec. 2. A Credit Suisse spokesperson said the bank does "not comment on speculation." Finma's scrutiny adds to the challenges faced by Credit Suisse, which has been rocked by scandals in recent years.
Total: 7